Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Oncolytic HSV-1 (oHSV-1) for Treatment of Urologic Cancer
This project is to use genetic engineered “cold-sore” virus to treat prostate cancer. The virus is engineered to reduce its toxicity to normal tissues but can specifically attack and kill tumour cells. Meanwhile, the virus releases a group of anti-tumour immune stimulating factors to activate immune system to eliminate prostate tumour. This project will use a unique prostate tumour mouse model to test the virus.
Faculty Supervisor:
Paul Rennie
Student:
Partner:
Virogin Biotech Ltd
Discipline:
Life Sciences
Sector:
Biotechnology; Pharmaceuticals
University:
The University of British Columbia
Program:
Accelerate
Current openings
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find Projects
International
Load More
International
Load More
